According to the American Society of Clinical Oncology, surveillance for multiple endocrine neoplasia type 2  by annual measurement of serum calcitonin, serum calcium, serum parathyroid hormone, and catecholamines is recommended post-surgically to monitor for recurrence and complications for multiple endocrine neoplasia type 2.
Multiple endocrine neoplasia type 2 secondary prevention
Multiple endocrine neoplasia type 1 secondary prevention
Multiple endocrine neoplasia type 2 prevention
Multiple endocrine neoplasia type 2 future or investigational therapies
Multiple endocrine neoplasia type 1 future or investigational therapies
Multiple endocrine neoplasia type 2 medical therapy
Multiple endocrine neoplasia type 1 medical therapy
Addison's disease secondary prevention